| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. | J Invest Dermatol | 2010 | 1.07 |
| 2 | Interferon lambda: a new sword in cancer immunotherapy. | Clin Dev Immunol | 2011 | 1.04 |
| 3 | Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place? | Carcinogenesis | 2010 | 0.97 |
| 4 | Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma. | PLoS One | 2012 | 0.77 |